The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis

Published:2023-04 Issue: Volume:171 Page:83-94
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hendrikse C.S.E.,Theelen P.M.M.,van der Ploeg P.,Westgeest H.M.,Boere I.A.,Thijs A.M.J.,Ottevanger P.B.,van de Stolpe A.,Lambrechts S.,Bekkers R.L.M.,Piek J.M.J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference54 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

2. Morphological and molecular heterogeneity of epithelial ovarian cancer: therapeutic implications;Romero;EJC Suppl.,2020

3. Ovarian cancer statistics, 2018;Torre;CA Cancer J. Clin.,2018

4. Diagnosis and treatment of ovarian Cancer;Orr;Hematol. Oncol. Clin. North Am.,2018

5. Advances in ovarian cancer therapy;Cortez;Cancer Chemother. Pharmacol.,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro antiviral activity of eugenol on Singapore grouper iridovirus;Fish & Shellfish Immunology;2024-08

2. Ovarian cancer: Diagnosis and treatment strategies (Review);Oncology Letters;2024-07-18

3. 4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancer;JCI Insight;2024-06-06

4. Oncogenic Pathways and Targeted Therapies in Ovarian Cancer;Biomolecules;2024-05-15

5. Zebrafish Avatars: Toward Functional Precision Medicine in Low-Grade Serous Ovarian Cancer;Cancers;2024-05-09